Abstract
Honey bee ( Apis mellifera ) larvae are susceptible to the bacterial pathogen Paenibacillus larvae , which causes severe damage to bee colonies. Antibiotic treatment requires veterinary supervision in the USA, is not used in many parts of the world, perpetuates problems associated with antibiotic resistance and may necessitate residual testing in bee products. There is interest in using bacteriophages to treat infected colonies (bacteriophage therapy), and several trials are promising. Nevertheless, the safety of using biological agents in the environment must be scrutinized. In this study, we analysed the ability of P. larvae to evolve resistance to several different bacteriophages. We found that bacteriophage resistance rapidly developed in culture but often results in growth defects. Mutations in the bacteriophage-resistant isolates are concentrated in genes encoding potential surface receptors but are also observed in genes controlling general cellular functions and in two cases – lysogeny. Testing one of these isolates in bee larvae, we found it to have reduced virulence compared to the parental P. larvae strain. We also found that bacteriophages are likely able to counteract resistance evolution. This work suggests that while bacteriophage resistance may arise, its impact will likely be mitigated by reduced pathogenicity and secondary bacteriophage mutations that overcome resistance.